CHO Pharma, Inc. (TPEX:6586)

CHO Pharma Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-212.23	-306.09	-338.39	-205.93	-296.84
Depreciation & Amortization	25.9	28.28	39.85	39.08	41.24
Loss (Gain) From Sale of Assets	-	-	-	-	0.09
Asset Writedown & Restructuring Costs	-	52.73	-	6	-
Stock-Based Compensation	-14.3	-7.66	21.99	-13.84	-5.02
Other Operating Activities	-2.96	-2	-0.01	0	0.01
Change in Accounts Receivable	-0.75	-	0.06	-0.06	-
Change in Accounts Payable	-2.52	-52.68	38.24	-16.47	14.61
Change in Other Net Operating Assets	-10.52	-3.71	-11.24	-2.26	-2.81
Operating Cash Flow	-217.38	-291.13	-249.5	-193.47	-248.73
Capital Expenditures	-5.49	-2	-9.4	-2.64	-19.16
Sale (Purchase) of Intangibles	-	-	-	-	-3
Investment in Securities	54.8	-1,860	-	-	-
Other Investing Activities	0.09	2.57	0.39	-0.39	3.12
Investing Cash Flow	49.4	-1,859	-9.01	-3.03	-19.04
Long-Term Debt Repaid	-14.04	-11.7	-14.4	-12.52	-12.24
Net Debt Issued (Repaid)	-14.04	-11.7	-14.4	-12.52	-12.24
Issuance of Common Stock	-	1,860	0.5	1.21	2.65
Financing Cash Flow	-14.04	1,849	-13.9	-11.31	-9.59
Foreign Exchange Rate Adjustments	0.04	0.05	0.09	-0.6	-0.71
Net Cash Flow	-181.98	-301.87	-272.33	-208.41	-278.07
Free Cash Flow	-222.87	-293.13	-258.9	-196.11	-267.89
Free Cash Flow Margin	-6225.53%	-	-431501.67%	-5493.25%	-194121.74%
Free Cash Flow Per Share	-1.04	-1.53	-1.41	-1.07	-1.46
Cash Interest Paid	0.68	0.08	0.3	0.58	0.78
Cash Income Tax Paid	3.11	0.46	0.01	-	-0.01
Levered Free Cash Flow	-165.45	-206.15	-140.34	-128.96	-168.26
Unlevered Free Cash Flow	-165.02	-206.1	-140.15	-128.6	-167.78
Change in Net Working Capital	15.31	56.6	-26.72	19.65	-11.63

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.